Protease-activated receptor-4 and purinergic receptor P2Y12 dimerize, co-internalize, and activate Akt signaling via endosomal recruitment of β-arrestin

J Biol Chem. 2017 Aug 18;292(33):13867-13878. doi: 10.1074/jbc.M117.782359. Epub 2017 Jun 26.

Abstract

Vascular inflammation and thrombosis require the concerted actions of several different agonists, many of which act on G protein-coupled receptors (GPCRs). GPCR dimerization is a well-established phenomenon that can alter protomer function. In platelets and other cell types, protease-activated receptor-4 (PAR4) has been shown to dimerize with the purinergic receptor P2Y12 to coordinate β-arrestin-mediated Akt signaling, an important mediator of integrin activation. However, the mechanism by which the PAR4-P2Y12 dimer controls β-arrestin-dependent Akt signaling is not known. We now report that PAR4 and P2Y12 heterodimer internalization is required for β-arrestin recruitment to endosomes and Akt signaling. Using bioluminescence resonance energy transfer, immunofluorescence microscopy, and co-immunoprecipitation in cells expressing receptors exogenously and endogenously, we demonstrate that PAR4 and P2Y12 specifically interact and form dimers expressed at the cell surface. We also found that activation of PAR4 but not of P2Y12 drives internalization of the PAR4-P2Y12 heterodimer. Remarkably, activated PAR4 internalization was required for recruitment of β-arrestin to endocytic vesicles, which was dependent on co-expression of P2Y12. Interestingly, stimulation of the PAR4-P2Y12 heterodimer promotes β-arrestin and Akt co-localization to intracellular vesicles. Moreover, activated PAR4-P2Y12 internalization is required for sustained Akt activation. Thus, internalization of the PAR4-P2Y12 heterodimer is necessary for β-arrestin recruitment to endosomes and Akt signaling and lays the foundation for examining whether blockade of PAR4 internalization reduces integrin and platelet activation.

Keywords: ADP; Akt PKB; G protein-coupled receptor (GPCR); arrestin; dimerization; endosome; thrombin.

Publication types

  • Comparative Study

MeSH terms

  • Amino Acid Substitution
  • Animals
  • Bioluminescence Resonance Energy Transfer Techniques
  • COS Cells
  • Cell Line, Tumor
  • Chlorocebus aethiops
  • Endocytosis*
  • Endosomes / metabolism
  • Humans
  • Immunoprecipitation
  • Microscopy, Fluorescence
  • Protein Multimerization
  • Protein Transport
  • Proto-Oncogene Proteins c-akt / agonists*
  • Proto-Oncogene Proteins c-akt / metabolism
  • Receptor, PAR-1 / agonists
  • Receptor, PAR-1 / chemistry
  • Receptor, PAR-1 / genetics
  • Receptor, PAR-1 / metabolism
  • Receptors, Purinergic P2Y12 / chemistry
  • Receptors, Purinergic P2Y12 / genetics
  • Receptors, Purinergic P2Y12 / metabolism*
  • Receptors, Thrombin / agonists*
  • Receptors, Thrombin / chemistry
  • Receptors, Thrombin / genetics
  • Receptors, Thrombin / metabolism
  • Recombinant Fusion Proteins / chemistry
  • Recombinant Fusion Proteins / metabolism
  • Signal Transduction*
  • beta-Arrestin 2 / chemistry
  • beta-Arrestin 2 / metabolism*

Substances

  • ARRB2 protein, human
  • P2RY12 protein, human
  • Receptor, PAR-1
  • Receptors, Purinergic P2Y12
  • Receptors, Thrombin
  • Recombinant Fusion Proteins
  • beta-Arrestin 2
  • AKT1 protein, human
  • Proto-Oncogene Proteins c-akt
  • protease-activated receptor 4